Caspase 3

Caspase-3, in particular, (also known as CPP32/Yama/apopain) is formed from a 32 kDa zymogen that is cleaved into 17 kDa and 12 kDa subunits. When the procaspase is cleaved at a particular residue, the active heterotetramer can then be formed by hydrophobic interactions, causing four anti-parallel beta-sheets from p17 and two from p12 to come together to make a heterodimer, which in turn interacts with another heterodimer to form the full 12-stranded beta-sheet structure surrounded by alpha-helices that is unique to caspases. When the heterodimers align head-to-tail with each other, an active site is positioned at each end of the molecule formed by residues from both participating subunits, though the necessary Cys-163 and His-121 residues are found on the p17 (larger) subunit. == Function ==

-R1. Dashed grey lines represent multiple steps Caspase-3 is a crucial executioner protease in the apoptotic pathway, responsible for orchestrating the dismantling of cellular components during programmed cell death. Synthesized as an inactive zymogen, caspase-3 is activated by upstream initiator caspases-such as caspase-8 and caspase-9 through proteolytic cleavage, which exposes its active site and enables it to cleave a broad range of cellular substrates, including structural proteins, cell cycle regulators, and DNA repair enzymes. This proteolytic activity leads to hallmark features of apoptosis, such as chromatin condensation, DNA fragmentation, and the formation of apoptotic bodies, facilitating the orderly removal of dying cells. Caspase-3 has been found to be necessary for normal brain development as well as its typical role in apoptosis, where it is responsible for chromatin condensation and DNA fragmentation. It is now being shown that caspase-3 may play a role in embryonic and hematopoietic stem cell differentiation. == Enzymatic activity ==

Substrate specificity Under normal circumstances, caspases recognize tetra-peptide sequences on their substrates and hydrolyze peptide bonds after aspartic acid residues. Caspase 3 and caspase 7 share similar substrate specificity by recognizing tetra-peptide motif Asp-x-x-Asp. The C-terminal Asp is absolutely required while variations at other three positions can be tolerated. Caspase substrate specificity has been widely used in caspase based inhibitor and drug design. Mechanism of catalysis The catalytic site of caspase-3 involves the thiol group of Cys-163 and the imidazole ring of His-121. His-121 stabilizes the carbonyl group of the key aspartate residue, while Cys-163 attacks to ultimately cleave the peptide bond. Cys-163 and Gly-238 also function to stabilize the tetrahedral transition state of the substrate-enzyme complex through hydrogen bonding. Caspase-3 is active over a broad pH range that is slightly higher (more basic) than many of the other executioner caspases. This broad range indicates that caspase-3 will be fully active under normal and apoptotic cell conditions. == Regulation ==

Activation Caspase-3 is activated in the apoptotic cell both by extrinsic (death ligand) and intrinsic (mitochondrial) pathways. The zymogen feature of caspase-3 is necessary because if unregulated, caspase activity would kill cells indiscriminately. As an executioner caspase, the caspase-3 zymogen has virtually no activity until it is cleaved by an initiator caspase after apoptotic signaling events have occurred. One such signaling event is the introduction of granzyme B, which can activate initiator caspases, into cells targeted for apoptosis by killer T cells. This extrinsic activation then triggers the hallmark caspase cascade characteristic of the apoptotic pathway, in which caspase-3 plays a dominant role. These molecules are sufficient to activate caspase-3 in vitro, but other regulatory proteins are necessary in vivo. Inhibition One means of caspase inhibition is through the IAP (inhibitor of apoptosis) protein family, which includes c-IAP1, c-IAP2, XIAP, and ML-IAP. == Interactions ==

Caspase 3 has been shown to interact with: • CASP8 • NMT2 • CFLAR • DCC • GroEL • HCLS1 • Survivin • TRAF3 • XIAP • NFE2L2 == See also ==